|
References: A
- Aguglia E., M. Casacchia, G. B. Cassano, C. Faravelli, G. Ferrari, P. Giordano, P. Pancher, L. Ravizza, M. Trabucchi, F. Bolino, A. Carpato, D. Berardi, G. Provenzano, R. Brugnoli, and R. Rozzini.
1993. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int. Clin. Psychopharmacol. 8:197-202.
- Alvarez, N., R. A. Kern, N. N. Cain, D. L. Coulter, M. Iivanainen, and A. T. Plummer. 1998. Antiepileptics. In S. Reiss and M. G. Aman (eds.), Psychotropic medication and developmental disabilities:
The international consensus handbook. Columbus: Ohio State Univ. Nisonger Center.
- Aman, M. G. 1982. Stimulant drug effects in developmental disorders and hyperactivity: Toward a resolution of disparate findings. J. Autism Dev. Disord. 12:385-398.
- Aman, M. G., and R. A. Kern. 1990. The efficacy of folic acid in the developmental disabilities. J. Child Adolesc. Psychopharmacology 1:285-295.
- Aman, M. G., and A. Madrid. 1999. Atypical antipsychotics in persons with developmental disabilities. Ment. Retard. Dev. Disabil. Res. Rev. 5:253-263.
- Aman, M. G., and A. J. White. 1988. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents. J. Autism Dev. Disord. 18:355-366.
- Aman, M. G., R. E. Marks, S. H. Turbott, C. P. Wilsher, and S. N. Merry. 1991a. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children. J. Am. Acad. Child Adolesc.
Psychiatry 30:246-256.
- ---. 1991b. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: Effects on cognitive-motor performance. J. Am. Acad. Child Adolesc. Psychiatry 30:816-824.
- Amaria, R. N., L. L. Billeisen, and R. J. Hagerman. 2001. Medication use in fragile X syndrome. Ment. Health Aspects Dev. Disabil. In press.
- Ambrosini, P. J., K. D. Wagner, J. Biederman, I. Glick, C. Tan, J. Elia, J. R. Hebeler, H. Rabinovich, J. Lock, and D. Geller. 1999. Multicenter open-label sertraline study in adolescent outpatients
with major depression. J. Am. Acad. Child Adolesc. Psychiatry 38:566-572.
- American Academy of Pediatrics, Committee on Genetics. 1996. Health supervision for children with fragile X syndrome. Pediatrics 98:297-300.
- American Psychiatric Association. 1973. APA task force on vitamin therapy in psychiatry: Mega vitamin and ortho molecular therapy in psychiatry. Washington, D.C.
- Arendt, J., M. Aldhous, J. English, V. Marks, J. H. Arendt, M. Marks, and S. Folkard. 1987. Some effects of jet lag and their alleviation by melatonin. Ergonomics 30:1379-1393.
- Arnold, L. E. 1993. Clinical pharmacological issues in treating psychiatric disorders in patients with mental retardation. Ann. Clin. Psychiatry 5:189-197.
- Arnold, L. E., K. Gadow, D. A. Pearson, and C. K. Varley. 1996. Stimulants in patients with mental retardation. In M. Aman and S. Reiss (eds.), Handbook of psychopharmacology and mental retardation.
Washington, D.C.: American Association on Mental Retardation.
|
This article is not intended to give medical advice for individual cases. Any change in medical treatment
should be done in consultation with appropriate medical personnel. This article is written for medical professionals. Some of the terms will be unfamiliar to those who are not trained in medical fields.
*This article is from the chapter on treatment in the 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research edited
by Randi Jenssen Hagerman, M.D. and Paul Hagerman, M.D., Ph.D., to be published May 2002. It is included with permission from The Johns Hopkins University Press. References to other chapters refer to chapters in
the book which are not included as part of this website.
The complete 3rd edition of Fragile X Syndrome: Diagnosis, Treatment, and Research can be ordered from the National Fragile X Foundation by calling
1-800-688-8765 or from The Johns Hopkins University Press at 1-800-537-5487.
|
|
Medical Follow-up Pharmacotherapy Future Prospects
Outline Medications Medical Conditions
References: A, B, C, D, EF, G, H, IJ, K, L, M, NOP, QR, S, T, UVWXYZ
|
